inTEST Corp (INTT) Tops Q2 EPS by 2c
Get Alerts INTT Hot Sheet
Price: $13.59 -2.37%
Financial Fact:
Income tax expense (benefit): 631K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income tax expense (benefit): 631K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
inTEST Corp (NYSE: INTT) reported Q2 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $21.8 million versus the consensus estimate of $20.34 million.
GUIDANCE:
inTEST Corp sees Q3 2021 EPS of $0.21-$0.25, versus the consensus of $0.23. inTEST Corp sees Q3 2021 revenue of $20.5-21.5 million, versus the consensus of $20.2 million.
For earnings history and earnings-related data on inTEST Corp (INTT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share